Tsuyoshi Oikawa

1.5k total citations
29 papers, 1.2k citations indexed

About

Tsuyoshi Oikawa is a scholar working on Molecular Biology, Nephrology and Clinical Biochemistry. According to data from OpenAlex, Tsuyoshi Oikawa has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Nephrology and 5 papers in Clinical Biochemistry. Recurrent topics in Tsuyoshi Oikawa's work include Peroxisome Proliferator-Activated Receptors (11 papers), Metabolism and Genetic Disorders (5 papers) and Acute Kidney Injury Research (4 papers). Tsuyoshi Oikawa is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (11 papers), Metabolism and Genetic Disorders (5 papers) and Acute Kidney Injury Research (4 papers). Tsuyoshi Oikawa collaborates with scholars based in Japan and United States. Tsuyoshi Oikawa's co-authors include Savério Bellusci, Glenn E. Winnier, Brigid L.M. Hogan, Agnes B. Fogo, Michael L. Freeman, Douglas E. Vaughan, Junji Kakuchi, Patricia A. Labosky, Soichiro Okubo and Hisahiro Yoshida and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Development.

In The Last Decade

Tsuyoshi Oikawa

29 papers receiving 1.2k citations

Peers

Countries citing papers authored by Tsuyoshi Oikawa

Since Specialization

Citations

This map shows the geographic impact of Tsuyoshi Oikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuyoshi Oikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuyoshi Oikawa more than expected).

Fields of papers citing papers by Tsuyoshi Oikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuyoshi Oikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuyoshi Oikawa. The network helps show where Tsuyoshi Oikawa may publish in the future.

Co-authorship network of co-authors of Tsuyoshi Oikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuyoshi Oikawa. A scholar is included among the top collaborators of Tsuyoshi Oikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuyoshi Oikawa. Tsuyoshi Oikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Urinary liver‐type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone‐induced acute kidney injury 2023 ·Nephrology ·Keiichi Ohata, Takeshi Sugaya, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tsuyoshi Oikawa, Hiroshi Nagabukuro, (unknown), Atsuko Kamijo‐Ikemori, (unknown), Dai Nakae, Eisei Noiri, Katsuhiro Miyajima	3
2	Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report 2022 ·Open Veterinary Journal ·S Takashima, (unknown), Keiichi Ohata, Tsuyoshi Oikawa, Takeshi Sugaya, (unknown), Sanae SHIBATA, Naohito NISHII	1
3	Structural Development of Silicon‐Containing Retinoids: Structure–Activity Relationship Study of the Hydrophobic Pharmacophore of Retinobenzoic Acids Using Silyl Functionalities 2022 ·ChemMedChem ·Tsuyoshi Oikawa, Shinya Fujii, (unknown), Hiroyuki Masuno, Emiko Kawachi, Hiroyuki Kagechika	4
4	Design, synthesis and antitumor activity of phthalazine-1,4-dione-based menaquinone analogs 2021 ·Bioorganic & Medicinal Chemistry Letters ·Shinya Fujii, Takahiro Miura, Tsuyoshi Oikawa, Xian‐Yang Qin, Soichi Kojima, Hiroyuki Kagechika	1
5	Renal expression and urinary excretion of liver-type fatty acid-binding protein in cats with renal disease 2020 ·Journal of Veterinary Internal Medicine ·Masaaki Katayama, Keiichi Ohata, (unknown), (unknown), Nobuko Wakamatsu, (unknown), Tetsuro Yamashita, Tsuyoshi Oikawa, Takeshi Sugaya, Masao Miyazaki	8
6	Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1a receptor expression 2017 ·European Journal of Pharmacology ·Keiichi Ohata, Atsuko Kamijo‐Ikemori, Takeshi Sugaya, (unknown), Takashi Nakamura, Takayo Murase, Tsuyoshi Oikawa, Seiko Hoshino, (unknown), (unknown), Kenjiro Kimura, Yugo Shibagaki	15
7	Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem Cells 2016 ·PLoS ONE ·Tokunori Yamamoto, Masato Furuhashi, Takeshi Sugaya, Tsuyoshi Oikawa, Megumi Matsumoto, Yasuhito Funahashi, Yoshihisa Matsukawa, Momokazu Gotoh, Tetsuji Miura	28
8	Studies directed toward synthesis of taepeenin D: construction of the C4 stereogenic center and the CD benzofuran rings 2016 ·Tetrahedron Letters ·(unknown), (unknown), Tsuyoshi Oikawa, Masato Oikawa, Yuichi Ishikawa	10
9	The biomarker for CKD: urinary L-FABP ― from molecular function to clinical significance 2015 ·Folia Pharmacologica Japonica ·M. Okazaki, Tsuyoshi Oikawa, Takeshi Sugaya	2
10	Identification of a small-molecule inhibitor of the interaction between Survivin and Smac/DIABLO 2010 ·Biochemical and Biophysical Research Communications ·Tsuyoshi Oikawa, Yuka Unno, Kenji Matsuno, Jun‐ichi Sawada, Naohisa Ogo, Kiyoshi Tanaka, Akira Asai	23
11	Continuous observation on heart-disease-model mice using biomagnetic measurement system 2008 ·Journal of Physics Conference Series ·Yutaka Kasai, Tsuyoshi Oikawa, Yutaka Saitoh, Yumie Ono, Atsushi Ishiyama, Nahoko Kasai, (unknown), Kazuo Chinone	2
12	Molecular and clinical studies of Dents disease in Japan: biochemical examination and renal ultrasonography do not predict carrier state 2004 ·Clinical Nephrology ·Takashi Matsuyama, Midori Awazu, Tsuyoshi Oikawa, (unknown), (unknown), T Igarashi	5
13	Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition 1997 ·Kidney International ·Tsuyoshi Oikawa, Michael L. Freeman, (unknown), Douglas E. Vaughan, Agnes B. Fogo	178
14	EVIDENCE FROM NORMAL EXPRESSION AND TARGETED MISEXPRESSION THAT BONE MORPHOGENETIC PROTEIN-4 (BMP-4) PLAYS A ROLE IN MOUSE LUNG MORPHOGENESIS.• 1992 1996 ·Pediatric Research ·(unknown), Savério Bellusci, Glenn E. Winnier, Tsuyoshi Oikawa, Brigid L.M. Hogan	19
15	Evidence from normal expression and targeted misexpression that Bone Morphogenetic Protein-4 (Bmp-4) plays a role in mouse embryonic lung morphogenesis 1996 ·Development ·Savério Bellusci, (unknown), Glenn E. Winnier, Tsuyoshi Oikawa, Brigid L.M. Hogan	396
16	Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. 1995 ·Journal of Clinical Investigation ·Fumio Niimura, Patricia A. Labosky, Junji Kakuchi, Soichiro Okubo, Hisahiro Yoshida, Tsuyoshi Oikawa, Toshihiro Ichiki, Allen J. Naftilan, Agnes B. Fogo, Tadashi Inagami	275
17	Synthesis and Structure-Activity Relationships of Gelatinase Inhibitors Derived from Matlystatins. 1995 ·Chemical and Pharmaceutical Bulletin ·(unknown), K. Tanzawa, (unknown), Tsuyoshi Oikawa, (unknown), Kohei Shimada, Yukio Sugimura	30
18	Mechanisms and significance of proteinuria 1995 ·Nephrology ·Tsuyoshi Oikawa, Agnes B. Fogo	4
19	Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan 1993 ·Acta Paediatrica ·Shin‐ichiro Hamano, (unknown), Takahiro Nara, Takashi Seki, (unknown), Tsutomu Oishi, Kosuke Joh, Tsuyoshi Oikawa, (unknown), Yoshihiro Ogawa, Shunji Akashi	45
20	[Prophylactic use of concentrated antithrombin III preparation in children with nephrotic syndrome]. 1993 ·PubMed ·Tsuyoshi Oikawa, Yuta Muramatsu, (unknown), Nobuo Usui	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact